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Open Access

Ultra-wide-field retinal imaging in the
management of non-infectious retinal vasculitis
Henry A Leder1,2, John P Campbell1,3, Yasir J Sepah1, Theresa Gan4, James P Dunn4, Elham Hatef1, Brian Cho1,
Mohamed Ibrahim1, Millena Bittencourt1, Roomasa Channa1, Diana V Do1,5 and Quan Dong Nguyen1,5*

Abstract
Background: The purpose of this study is to describe and quantify the benefit of ultra-wide-field imaging and
fluorescein angiography (FA) in the management of non-infectious retinal vasculitis. In this prospective
observational cohort series, patients with non-infectious retinal vasculitis were evaluated and enrolled by four
investigators from the Divisions of Retina and Ocular Immunology at the Wilmer Eye Institute. In each patient,
disease activity and the need for management changes were assessed, based on clinical examination with or
without standard (60°) imaging and then with the addition of ultra-wide-field pseudo-color scanning laser
ophthalmoscope (SLO) images and FA using the Optos ultra-wide-field SLO (Optos Panoramic 200MA™, Optos PLC,
Dunfermline, Scotland, UK). A standardized questionnaire was completed by each investigator at the time of the
clinical evaluation.
The primary outcome was the percentage of patients whose management was changed by clinical examination
and standard FA, compared with clinical examination plus ultra-wide-field imaging. The secondary outcome was the
percentage of patients whose disease was determined to be active based on each modality.
Results: Seventy-one visits from 23 patients were reviewed and analyzed. Based on examination plus ultra-wide-field
imaging and ultra-wide-field angiography, disease activity was detected in 48/71 (68%) compared with 32/71 (45%)
based on examination and standard FA (P = 0.0095). Based on the clinical examination alone, the decision to alter
management was made in 4 of 71 visits (6%), and an additional 3 of 71 (4%) based on simulated standard FA. The
addition of ultra-wide-field SLO pseudo-color images altered management in an additional 10/71 visits (14%), and
36/71 (51%) with the addition of ultra-wide-field FA.
Conclusions: Ultra-wide-field fluorescein imaging and angiography can provide additional information that may be
important and relevant in the management of retinal vasculitis.
Keywords: Non-infectious retinal vasculitis, Fluorescein angiography, Ultra-wide-field imaging

Background
Non-infectious retinal vasculitis is a challenging disease
to treat. Treatment must be titrated to minimize side
effects while preserving vision. Disease activity is
monitored through a combination of patient symptoms,
clinical examination (including slit lamp, indirect ophthalmoscopy, and direct contact lens biomicroscopy),
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and retinal imaging studies [1]. Vascular leakage, an important element of retinal vasculitis, is best appreciated
and detected with fluorescein angiography (FA). Conventional retinal photography, including FA, is limited in
its field of view. Most fundus cameras can capture only
30° to 60° of the fundus at a time. While sweeps of the
retina can be performed to sample larger areas of the
retina, such an approach cannot image the entire retina
simultaneously. The limited view makes it difficult to
correctly locate peripheral lesions and to confirm/compare changes over time. The clinician is left relying on
diagrams in clinic charts, standard photographs, and
memory to assess disease progression.

© 2013 Leder et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
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There are several models of wide-field imaging
devices. The Optos P200 (Optos PLC, Dunfermline,
Scotland, UK) uses a scanning laser ophthalmoscope (SLO)
to image 200° of the retina at a time. It is also capable of
fluorescein angiography transiting the same 200° area. Such
capabilities make it ideal for monitoring progressive peripheral retinal vascular diseases and may be helpful in the
clinical management of posterior uveitis [2,3].
Several case reports have found that ultra-wide-field
imaging with FA is well tolerated by patients, can image
through small pupils, and can significantly contribute to
the management of retinal disease, though there can be
a number of imaging artifacts that interfere with image
interpretation [2]. It can be useful in a wide variety of retinal vascular disorders including uveitis, cytomegalovirus
retinitis, vein occlusions, diabetes, as well as non-vascular
conditions such as retinal detachment, retinal tumors, and
choroidal tumors. However, these publications are limited
to retrospective case reports or series [4-15].
Kaines et al. reviewed five cases of posterior uveitis
seen at their institution and identified several attributes
of the SLO ultra-wide-field imaging system that aided in
the diagnosis and management of their patients [3]. They
noted that the high-resolution images allowed clear documentation of peripheral retinal lesions and greatly eased
longitudinal comparisons for disease activity and progression. Areas of neovascularization and non-perfusion were
easily identified, aiding targeted pan-retinal photocoagulation. In several patients, they also noted peripheral angiographic findings that suggested disease activity in the
absence of clinical evidence of the disease.
The index study employed the use of ultra-wide-field
imaging modality prospectively in the management of
patients with non-infectious retinal vasculitis to determine whether the added information provided by the
ultra-wide-field images would alter management compared
with standard examination and standard (60°) imaging.

Results
Seventy-one visits of 23 consented patients were analyzed
in this prospective observational case series. All patients
had ultra-wide-field imaging following their clinical examination. Associated diagnoses of the 23 patients prior to
enrollment into the study included the following: 6 with
panuveitis, 3 with biopsy-proven sarcoidosis, 3 with intermediate uveitis, 2 with Adamantiades-Behcet’s disease, 1
with Wegener’s disease, and 8 with no associated syndrome (idiopathic).
Figure 1 demonstrates how the simulated FA and
clinical examination may detect disease activity (mild
perifoveal and perivascular leakage); however, additional
findings seen on ultra-wide-field imaging (significant
diffuse, peripheral vascular leakage) may affect the
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Figure 1 Color photograph and fluorescein angiography. (A)
Wide-field color image and (B) corresponding fluorescein
angiography of a 14-year-old boy with intermediate uveitis and
retinal vasculitis. The white circle simulates the area covered by a
typical 60° view.

investigators’ overall assessment of disease activity and
hence may alter plans of management.
Table 1 and Figure 2 depict the percentage of patients who demonstrated disease activity and whether
management was changed based on the four possible
combinations of examination and imaging. Disease activity was detected in 27/71 (38%) of patient visits based on
clinical examination alone and an additional 5 of 71
(45%) based on simulated conventional FA. The addition
of ultra-wide-field SLO pseudo-color images detected
disease activity in 4 additional patient visits (51%), and
ultra-wide-field FA identified an additional 12 patient
visits (68%) as ‘active’ in whom neither clinical examination, standard FA, or even ultra-wide-field photographs
had convincingly demonstrated disease activity. Based on
the clinical examination alone, the decision to alter management was made in 4 of 71 visits (6%), and an additional
3 of 71 (4%) based on simulated standard FA. Thus, the
investigator made the decision to alter management in 7
of 71 (10%) of patient visits based on examination and
standard FA. The addition of ultra-wide-field SLO
pseudo-color images altered management in 17/71 visits
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Table 1 Percentage of patients who demonstrated disease activity and whether management was changed based on
examination and imaging
Disease activity (n = 71) (%)
Exam

38.02

+FA

45.07

+Wide-field images

50.70

+Wide-field FA

67.60

Change in management (n = 71) (%)

P

P

5.63
0.49a
0.20a
a

0.47a

10

0.01a

24
b

0.0006 and 0.0095

51

a

<0.0001 and <0.0001b

a

Vs. clinical examination alone; bvs. examination and FA.

(24%), and the addition of ultra-wide-field FA altered
management in 36/71 (51%) of patients.

Discussion
In the index, prospective, observational study of patients
with non-infectious vasculitis, the first, to our knowledge, to evaluate systematically and prospectively the
role of ultra-wide-field imaging in retinal vasculitis, our
results suggest that ultra-wide-field imaging may alter
management decisions compared to standard-of-care
imaging and clinical examination. Such differences are
likely due to the ability to image the peripheral retinal
and angiographic findings that are not easily visualized
or identified without ultra-wide-field imaging. Both the
determination of disease ‘activity’ and disease management
differed significantly with the use of ultra-wide-field
imaging compared with standard imaging. Management
decisions were significantly altered, suggesting that qualitative and quantitative differences in the degree of disease
activity seen on ultra-wide-field imaging may play an
important role.
Our study was designed to investigate the potentials of
wide-angle imaging in making management decisions in
80%
Disease Activity
70%

Change in Management

60%
50%
40%
30%
20%
10%
0%
Exam

IVFA

Wide Field Wide Field
Images
IVFA

Figure 2 Active disease and change in management with
increasing information.

patients with non-infectious vasculitis, but not to determine the specific changes in patient management.
Therefore, we did not obtain data on the management
decisions that were made. Future investigations are
needed to evaluate the degree of alteration (i.e., changing
the dose of prednisone, addition of immunomodulatory
therapy) associated with the additional information
provided by the wide-angle imaging system and whether
such alterations have led to additional benefits to the
patients.
There are limitations to our study. The examining
clinicians were not masked to 60°, as would have been
ideal. Given the demands of clinical care and for practical and ethical reasons, we were unable to perform
both the standard FA and the ultra-wide-field FA at the
same visit. Thus, to determine disease activity and management based on examination and ‘conventional’ (30°
or 60°) FA, investigators were asked to limit their assessment to the central 30° or 60° (based on preference) of
the ultra-wide-field images (simulated conventional FA).
Simulated peripheral sweeps were permitted if the investigator indicated that based on their clinical examination, peripheral sweeps were needed. The clinicians had
to restrict themselves to the central image to evaluate
the patient before considering the entire image. We
attempted to limit bias by prospectively evaluating the
ultra-wide-field imaging and acquiring the activity and
management data based on the clinical examination
prior to sending the patient for imaging, though the
possibility of investigators biasing their responses to the
standard FA question cannot be excluded with our study
design.
In addition, it is also possible that there is selection
bias in this study population towards the investigators
selecting patients who may be more likely to have peripheral retinal findings that would change management,
and not be representative of all patients with retinal
vasculitis. Future studies may choose to enroll all
patients with posterior uveitis consecutively to eliminate
this potential bias.
In addition, ‘retinal vasculitis’ is a difficult entity to
define. The Standardization of Uveitis Nomenclature
Working Group [1] was unable to agree on a definition
of vasculitis. We defined vasculitis as a retinal vascular
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Figure 3 Data sheet for clinical decision making.

occlusion, with leakage on fluorescein, overlying vitritis,
vascular sheathing, and retinal hemorrhages in the context of ophthalmic inflammation. The definition of retinal vasculitis remains an area of debate, and different
clinicians may define vasculitis using different criteria.
The index study was not designed to determine the
utility of FA (standard or ultra-wide-field) in patients
who do not appear to have active disease, though we did
note a number of patients who demonstrated evidence
of disease activity on peripheral angiography and who
clinically appeared to have quiescent disease. The clinical significance of this ‘additionally noted’ disease activity is unknown since ultra-wide-field imaging modality

has not previously been used in clinical practice or clinical trials.

Conclusions
Our study represents the first attempt to investigate prospectively the use of ultra-wide-field imaging and angiography in patients with non-infectious retinal vasculitis.
The findings from our study suggest that the additional
information provided by ultra-wide-field imaging may
allow earlier detection of active vasculitis, which may
lead to earlier treatment and perhaps better patient
outcomes. Ultra-wide-field imaging altered management
decisions compared to standard-of-care imaging and/or
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clinical examination of patients with retinal vasculitis.
The decision to alter management may be due to the
ability of such systems to detect disease activity in the
periphery, such as angiographic findings, not easily
visualized or identified with examination or standard imaging alone. Additional longitudinal studies with larger
patient populations are required to determine the utility
and application of ultra-wide-field imaging in the management of patients with retinal vasculitis. It is possible that
such studies will demonstrate improved patient outcomes
with clinical management based on findings detected on
ultra-wide-field photography and angiography.

Methods
In this prospective, observational study of patients with
non-infectious retinal vasculitis, disease activity and
changes in management were assessed based on clinical
examination with or without standard (60°) imaging and
then with the addition of ultra-wide-field pseudo-color
SLO images and FA using the Optos ultra-wide-field
SLO (Optos Panoramic 200MA™, Optos PLC). New and
established patients in the Divisions of Retina and
Ocular Immunology at the Wilmer Eye Institute were
evaluated, screened, and recruited by four co-investigators. A standardized questionnaire (Figure 3) was
completed by each investigator at the time of the clinical
evaluation. For practical and ethical reasons, we were
unable to perform both the standard FA and the ultrawide-field FA at the same visit. Thus, to determine disease activity and management based on examination and
standard (60°) FA, investigators were asked to limit their
assessment to the central 60° of the ultra-wide-field
images. Simulated peripheral sweeps were permitted if the
investigator indicated that based on their clinical examination, peripheral sweeps were needed. The images were
evaluated for signs of activity, which include but are not
limited to hemorrhages, vascular occlusions, perivascular
sheathing, and leakage. The presence or absence of these
signs was noted and compared to previous images when
applicable.
The primary outcome was the percentage of patients
whose management was changed by clinical exam and
standard FA, compared with examination plus ultrawide-field imaging. The secondary outcome was the percentage of patients whose disease was determined to be
active with each modality. The primary and secondary
outcome measures were analyzed in terms of proportions
(i.e., proportion of patients who were determined to be active based on ultra-wide-field imaging compared with
examination and standard FA) using the pretest function
in Stata v11.0 (College Station, TX, USA).
The Institutional Review Board approval was obtained
from the Johns Hopkins University School of Medicine
before the study enrolled any patients. Written, informed
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consent was obtained from all patients included in this
study. The research adhered to the tenets of the Declaration of Helsinki and was in accordance with all local,
state, and federal regulations, including HIPAA.
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